SCHEMBL10689367

SCHEMBL10689367

CCCCC(=O)N(c1ccccc1)c1ccc(OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R2 Q9NPC1 3/20 0.54
POLB P06746 1/20 0.50
TRPM8 Q7Z2W7 2/20 0.49
ALOX5 P09917 2/20 0.48
MTNR1A P48039 1/20 0.47
MTNR1B P49286 1/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
NPBWR1 P48145 1/20 0.46
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
TSHR P16473 1/20 0.44
LMNA P02545 1/20 0.44
PTGIR P43119 1/20 0.44
PTGDR Q13258 1/20 0.44
CYP2C8 P10632 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.44
PTGS2 P35354 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7978813 0.87 ALDH1A1 (0.55) LTB4R2POLBKMT2ATSHR
SCHEMBL2984167 0.82 NPC1 (0.53) LTB4R2POLBALOX5KMT2AMEN1
SCHEMBL18240156 0.81 NPC1 (0.54) LTB4R2POLBKMT2AMEN1TSHR
SCHEMBL12472589 0.81 NPC1 (0.54) LTB4R2POLBKMT2AMEN1TSHR
SCHEMBL7643097 0.81 NPC1 (0.54) LTB4R2POLBKMT2AMEN1TSHR
SCHEMBL18240146 0.81 NPC1 (0.54) LTB4R2POLBKMT2AMEN1TSHR
SCHEMBL28533625 0.81 NPC1 (0.54) LTB4R2POLBKMT2AMEN1TSHR
SCHEMBL9471594 0.80 TRPM8 (0.52) POLBTRPM8ALOX5MTNR1AMTNR1B
SCHEMBL2205203 0.79 LTB4R2 (0.52) LTB4R2POLBKDM4EKMT2A
SCHEMBL18425653 0.78 LTB4R2 (0.77) LTB4R2CYP2C8CYP2C9CYP2C19PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0270093-A2 Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties TANABE SEIYAKU CO., LTD. (JP) 1988-06-08 EP disclosed